Faculty

Steve Schwartz

Professor, Epidemiology

206-685-1799

Education

PhD Epidemiology, University of Washington, 1990
MPH Epidemiology, Yale University, 1984

Contact

206-685-1799

University of Washington
Box 351619
Department of Epidemiology
Hans Rosling Center for Population Health, 861B
Seattle, WA 98195

Research Areas

Research Interests

Dr. Schwartz primarily studies the etiology and outcomes of cancer. A major objective of his research is to determine the influence of genetic susceptibility, either alone or in combination with lifestyle and environmental risk factors. Current funded research projects include studies focusing on the genetic and non-genetic risk factors for HPV-cancers and testicular germ cell tumors. Other areas of cancer research focus on molecular markers for oral cancer outcomes and the health and well-being of adolescent and young adult cancer survivors. Among his other responsibilities in the field of cancer epidemiology, he serves as Principal Investigator of the Cancer Surveillance System, a population-based cancer registry at the Fred Hutchinson Cancer Research Center.

Recent Publications (PubMed)

Cocaine use and head and neck cancer risk: A pooled analysis in the International Head and Neck Cancer Epidemiology Consortium.
(2024 Feb)
Cancer Med 13(3): e7019
Zhang M, Chen C, Li G, Koric A, Lee YA, Morgenstern H, Schwartz SM, Sturgis EM, Boffetta P, Hashibe M, Zhang ZF
Association of Major Adverse Financial Events and Later-Stage Cancer Diagnosis in the United States.
(2024 Mar 20)
J Clin Oncol 42(9): 1001-1010
Warren JL, Mariotto AB, Stevens J, Davidoff AJ, Shankaran V, Ward KC, Wu XC, Schwartz SM, Penberthy L, Yabroff KR
Epidemiology of Cancer.
(2024 Jan 4)
Clin Chem 70(1): 140-149
Schwartz SM
Impact on the Volume of Pathology Reports Before and During the COVID-19 Pandemic in SEER Cancer Registries.
(2023 Nov 1)
Cancer Epidemiol Biomarkers Prev 32(11): 1591-1598
Chtourou A, Sanchez PV, Golden T, Chen HS, Schwartz SM, Wu XC, Hernandez BY, Harrison JN, Penberthy L, Negoita S
Use of the Decipher genomic classifier among men with prostate cancer in the United States.
(2023 Aug 31)
JNCI Cancer Spectr 7(5):
Zaorsky NG, Proudfoot JA, Jia AY, Zuhour R, Vince R Jr, Liu Y, Zhao X, Hu J, Schussler NC, Stevens JL, Bentler S, Cress RD, Doherty JA, Durbin EB, Gershman S, Cheng I, Gonsalves L, Hernandez BY, Liu L, Morawski BM, Schymura M, Schwartz SM, Ward KC, Wiggins C, Wu XC, Shoag JE, Ponsky L, Dal Pra A, Schaeffer EM, Ross AE, Sun Y, Davicioni E, Petkov V, Spratt DE
Show complete publication list